The valuation of prenatal life in economic evaluations of perinatal interventions

Judit Simon, Stavros Petrou and Alastair Gray

Health Economics, 2009, vol. 18, issue 4, 487-494

Abstract: Perinatal interventions delivered during the prenatal period have the potential to directly impact prenatal life. The decision on when to begin ‘counting’ the life of an infant in the calculus has received little attention in previous economic evaluations of perinatal interventions. We illustrate, using data from a recent trial‐based economic evaluation of magnesium sulphate given to women with pre‐eclampsia to prevent eclampsia, how different definitions of when human life commences can have a significant impact upon cost‐effectiveness estimates based on composite outcome measures such as life years or quality‐adjusted life years gained or disability‐adjusted life years averted. Further, we suggest ways in which methods in this area can be improved. Copyright © 2008 John Wiley & Sons, Ltd.

Date: 2009
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://doi.org/10.1002/hec.1375

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wly:hlthec:v:18:y:2009:i:4:p:487-494

Access Statistics for this article

Health Economics is currently edited by Alan Maynard, John Hutton and Andrew Jones

More articles in Health Economics from John Wiley & Sons, Ltd.
Bibliographic data for series maintained by Wiley Content Delivery ().